What is Tema Healthcare AI ETF's earnings per share (EPS)?

Tema Healthcare AI ETF (HLTH) reported diluted earnings per share of $-2.44 for fiscal year 2023. This represents a -86.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Tema Healthcare AI ETF Financials

HLTH

Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2023 Currency USD FYE December

This page shows Tema Healthcare AI ETF (HLTH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score pending refresh

We are recalculating Tema Healthcare AI ETF's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-5.78

Tema Healthcare AI ETF scores -5.78, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($6.9M) relative to total liabilities ($89.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

1/7

Tema Healthcare AI ETF passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Low Quality

0.37x

For every $1 of reported earnings, Tema Healthcare AI ETF generates $0.37 in operating cash flow (-$137.8M OCF vs -$373.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-340.7x

Tema Healthcare AI ETF earns $-340.7 in operating income for every $1 of interest expense (-$394.9M vs $1.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$70.9M

YoY-85.3%

Tema Healthcare AI ETF generated $70.9M in revenue in fiscal year 2023. This represents a decrease of 85.3% from the prior year.

EBITDA

-$338.6M

YoY-116.1%

Tema Healthcare AI ETF's EBITDA was -$338.6M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 116.1% from the prior year.

Net Income

-$373.5M

YoY-92.5%

Tema Healthcare AI ETF reported -$373.5M in net income in fiscal year 2023. This represents a decrease of 92.5% from the prior year.

EPS (Diluted)

$-2.44

YoY-86.3%

Tema Healthcare AI ETF earned $-2.44 per diluted share (EPS) in fiscal year 2023. This represents a decrease of 86.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$147.0M

YoY+9.3%

Tema Healthcare AI ETF generated -$147.0M in free cash flow in fiscal year 2023, representing cash available after capex. This represents an increase of 9.3% from the prior year.

Cash & Debt

$80.9M

YoY-66.5%

Tema Healthcare AI ETF held $80.9M in cash against $0 in long-term debt as of fiscal year 2023.

Dividends Per Share

N/A

Shares Outstanding

155M

YoY+3.3%

Tema Healthcare AI ETF had 155M shares outstanding in fiscal year 2023. This represents an increase of 3.3% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-556.6%

YoY-514.1pp

Tema Healthcare AI ETF's operating margin was -556.6% in fiscal year 2023, reflecting core business profitability. This is down 514.1 percentage points from the prior year.

Net Margin

-526.5%

YoY-486.3pp

Tema Healthcare AI ETF's net profit margin was -526.5% in fiscal year 2023, showing the share of revenue converted to profit. This is down 486.3 percentage points from the prior year.

Return on Equity

-149.2%

YoY-115.6pp

Tema Healthcare AI ETF's ROE was -149.2% in fiscal year 2023, measuring profit generated per dollar of shareholder equity. This is down 115.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$150.6M

YoY-12.2%

Tema Healthcare AI ETF invested $150.6M in research and development in fiscal year 2023. This represents a decrease of 12.2% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$9.2M

YoY-81.7%

Tema Healthcare AI ETF invested $9.2M in capex in fiscal year 2023, funding long-term assets and infrastructure. This represents a decrease of 81.7% from the prior year.

HLTH Income Statement

Metric	FY23	FY22	FY21	FY20	FY19
Revenue	$70.9M-85.3%	$483.5M-21.8%	$618.1M+2592.9%	$23.0M+246.4%	$6.6M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$150.6M-12.2%	$171.5M+300.3%	$42.8M+50.4%	$28.5M+33.0%	$21.4M
SG&A Expenses	$57.4M-40.9%	$97.1M+21.7%	$79.8M+233.3%	$23.9M+305.7%	$5.9M
Operating Income	-$394.9M-92.0%	-$205.7M-208.1%	$190.2M+521.5%	-$45.1M-117.3%	-$20.8M
Interest Expense	$1.2M+79.7%	$645K-93.4%	$9.8M	N/A	N/A
Income Tax	$4.8M+149.2%	-$9.7M-129.8%	$32.8M	$0	$0
Net Income	-$373.5M-92.5%	-$194.1M-324.6%	$86.4M+282.5%	-$47.4M-129.8%	-$20.6M
EPS (Diluted)	$-2.44-86.3%	$-1.31-322.0%	$0.59+120.3%	$-2.90-121.4%	$-1.31

Metric	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22
Revenue	$18.8M+7.6%	$17.5M+76.6%	$9.9M-60.0%	$24.8M-83.1%	$146.8M+110.9%	$69.6M-20.7%	$87.7M-51.1%	$179.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	$32.2M-13.1%	$37.1M+1.6%	$36.5M-18.3%	$44.7M-20.3%	$56.1M+32.1%	$42.5M-3.4%	$44.0M+52.8%	$28.8M
SG&A Expenses	$9.9M-37.7%	$15.8M+7.8%	$14.7M-13.2%	$16.9M-11.6%	$19.2M-25.2%	$25.6M+0.8%	$25.4M-5.6%	$26.9M
Operating Income	-$148.9M-130.1%	-$64.7M+24.2%	-$85.4M+10.9%	-$95.8M-148.2%	-$38.6M+42.7%	-$67.4M+34.2%	-$102.5M-3697.7%	$2.8M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$60K-98.7%	$4.7M	$0	$0+100.0%	-$5.3M-407.6%	-$1.0M+69.1%	-$3.4M	$0
Net Income	-$148.4M-216.0%	-$47.0M+44.0%	-$83.9M+11.0%	-$94.2M-199.0%	-$31.5M+52.5%	-$66.3M+33.1%	-$99.0M-3633.7%	$2.8M
EPS (Diluted)	N/A	$-0.31+43.6%	$-0.55+11.3%	$-0.62	N/A	$-0.45+32.8%	$-0.67-3450.0%	$0.02

HLTH Balance Sheet

Metric	FY23	FY22	FY21	FY20	FY19
Total Assets	$339.8M-51.1%	$694.6M-26.1%	$940.1M+197.2%	$316.3M	N/A
Current Assets	$110.4M-70.3%	$371.2M-44.6%	$670.0M+264.7%	$183.7M	N/A
Cash & Equivalents	$80.9M-66.5%	$241.5M-41.1%	$409.9M+237.1%	$121.6M+748.5%	$14.3M
Inventory	$14.0M-82.9%	$82.2M-7.0%	$88.4M+139.9%	$36.8M	N/A
Accounts Receivable	$1.4M-92.8%	$18.8M-82.1%	$104.6M+2409.3%	$4.2M	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$89.5M-24.2%	$118.1M-49.4%	$233.3M-44.1%	$417.7M	N/A
Current Liabilities	$43.5M-38.9%	$71.2M-57.4%	$166.9M+7.1%	$155.9M	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A
Total Equity	$250.3M-56.6%	$576.5M-18.4%	$706.8M+797.0%	-$101.4M-74.4%	-$58.1M
Retained Earnings	-$591.5M-171.3%	-$218.1M-808.0%	-$24.0M+78.3%	-$110.4M	N/A

Metric	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22
Total Assets	$339.8M-31.0%	$492.3M-6.0%	$523.9M-13.9%	$608.6M-12.4%	$694.6M-15.8%	$825.0M-9.7%	$914.1M-7.1%	$983.8M
Current Assets	$110.4M-42.6%	$192.2M-9.4%	$212.1M-26.1%	$287.0M-22.7%	$371.2M-28.9%	$521.9M-15.8%	$620.1M-11.6%	$701.4M
Cash & Equivalents	$80.9M-27.4%	$111.5M-13.3%	$128.6M-27.9%	$178.2M-26.2%	$241.5M-20.7%	$304.7M-16.1%	$363.1M-14.9%	$426.5M
Inventory	$14.0M-77.9%	$63.6M-7.0%	$68.4M-16.6%	$82.0M-0.2%	$82.2M-38.3%	$133.3M-4.1%	$139.0M+4.9%	$132.6M
Accounts Receivable	$1.4M+2.4%	$1.3M-22.7%	$1.7M-82.6%	$9.8M-47.7%	$18.8M-24.3%	$24.8M-54.1%	$54.0M-28.8%	$75.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$89.5M-13.5%	$103.5M+2.8%	$100.7M-10.7%	$112.7M-4.6%	$118.1M-49.8%	$235.1M-14.1%	$273.7M+5.8%	$258.6M
Current Liabilities	$43.5M-25.6%	$58.4M+2.4%	$57.0M-15.5%	$67.5M-5.2%	$71.2M-59.4%	$175.5M-16.5%	$210.0M+9.5%	$191.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$250.3M-35.6%	$388.8M-8.1%	$423.2M-14.7%	$495.9M-14.0%	$576.5M-2.3%	$590.0M-7.9%	$640.4M-11.7%	$725.1M
Retained Earnings	-$591.5M-33.5%	-$443.1M-11.9%	-$396.1M-26.9%	-$312.3M-43.2%	-$218.1M-16.9%	-$186.6M-55.1%	-$120.3M-466.9%	-$21.2M

HLTH Cash Flow Statement

Metric	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$137.8M-23.1%	-$111.9M-1084.5%	-$9.4M-110.2%	$92.7M+813.0%	-$13.0M
Capital Expenditures	$9.2M-81.7%	$50.2M-53.9%	$108.8M+43.2%	$76.0M+2481.8%	$2.9M
Free Cash Flow	-$147.0M+9.3%	-$162.1M-37.0%	-$118.3M-811.7%	$16.6M+204.3%	-$15.9M
Investing Cash Flow	-$19.8M+68.6%	-$63.0M+45.5%	-$115.7M-48.1%	-$78.1M-2553.6%	-$2.9M
Financing Cash Flow	-$3.0M+52.9%	-$6.4M-101.5%	$419.6M+318.6%	$100.2M+2676.8%	$3.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A

Metric	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22
Operating Cash Flow	-$28.7M-129.0%	-$12.5M+70.6%	-$42.7M+20.8%	-$53.9M-4.2%	-$51.7M-29.5%	-$39.9M+23.0%	-$51.8M-264.4%	$31.5M
Capital Expenditures	$1.4M-17.2%	$1.7M-26.2%	$2.2M-42.6%	$3.9M-44.2%	$7.0M-43.5%	$12.4M-31.1%	$18.0M+40.8%	$12.8M
Free Cash Flow	-$30.1M-112.0%	-$14.2M+68.4%	-$44.9M+22.3%	-$57.8M+1.6%	-$58.7M-12.2%	-$52.3M+25.1%	-$69.8M-472.7%	$18.7M
Investing Cash Flow	-$1.8M+49.8%	-$3.7M+38.9%	-$6.0M+28.0%	-$8.3M+17.5%	-$10.1M+44.8%	-$18.3M+11.4%	-$20.6M-46.7%	-$14.1M
Financing Cash Flow	-$10K+98.9%	-$897K+9.9%	-$996K+11.7%	-$1.1M+39.8%	-$1.9M-532.8%	-$296K+91.3%	-$3.4M-288.1%	-$873K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

HLTH Financial Ratios

Metric	FY23	FY22	FY21	FY20	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A
Operating Margin	-556.6%-514.1pp	-42.5%-73.3pp	30.8%+227.4pp	-196.6%+116.8pp	-313.4%
Net Margin	-526.5%-486.3pp	-40.1%-54.1pp	14.0%+220.3pp	-206.3%+104.7pp	-311.0%
Return on Equity	-149.2%-115.6pp	-33.7%-45.9pp	12.2%	N/A	N/A
Return on Assets	-109.9%-82.0pp	-27.9%-37.1pp	9.2%+24.2pp	-15.0%	N/A
Current Ratio	2.54-2.7	5.21+1.2	4.01+2.8	1.18	N/A
Debt-to-Equity	0.36+0.2	0.20-0.1	0.33	N/A	N/A
FCF Margin	-207.2%-173.7pp	-33.5%-14.4pp	-19.1%-91.5pp	72.4%+313.0pp	-240.6%

Metric	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-792.1%-421.9pp	-370.2%+492.7pp	-862.9%-475.9pp	-387.0%-360.7pp	-26.3%+70.6pp	-96.9%+20.0pp	-116.8%-118.4pp	1.6%
Net Margin	-789.6%-520.9pp	-268.8%+578.7pp	-847.5%-467.1pp	-380.4%-358.9pp	-21.5%+73.8pp	-95.3%+17.7pp	-112.9%-114.5pp	1.6%
Return on Equity	-59.3%-47.2pp	-12.1%+7.7pp	-19.8%-0.8pp	-19.0%-13.5pp	-5.5%+5.8pp	-11.2%+4.2pp	-15.5%-15.9pp	0.4%
Return on Assets	-43.7%-34.1pp	-9.5%+6.5pp	-16.0%-0.5pp	-15.5%-10.9pp	-4.5%+3.5pp	-8.0%+2.8pp	-10.8%-11.1pp	0.3%
Current Ratio	2.54-0.8	3.29-0.4	3.72-0.5	4.25-1.0	5.21+2.2	2.97+0.0	2.95-0.7	3.66
Debt-to-Equity	0.36+0.1	0.27+0.0	0.24+0.0	0.23+0.0	0.20-0.2	0.40-0.0	0.43+0.1	0.36
FCF Margin	-160.1%-78.8pp	-81.2%+372.5pp	-453.8%-220.4pp	-233.3%-193.4pp	-40.0%+35.2pp	-75.2%+4.5pp	-79.6%-90.1pp	10.4%

Frequently Asked Questions

What is Tema Healthcare AI ETF's annual revenue?

Tema Healthcare AI ETF (HLTH) reported $70.9M in total revenue for fiscal year 2023. This represents a -85.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Tema Healthcare AI ETF's revenue growing?

Tema Healthcare AI ETF (HLTH) revenue declined by 85.3% year-over-year, from $483.5M to $70.9M in fiscal year 2023.

Is Tema Healthcare AI ETF profitable?

No, Tema Healthcare AI ETF (HLTH) reported a net income of -$373.5M in fiscal year 2023, with a net profit margin of -526.5%.

What is Tema Healthcare AI ETF's EBITDA?

Tema Healthcare AI ETF (HLTH) had EBITDA of -$338.6M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

What is Tema Healthcare AI ETF's operating margin?

Tema Healthcare AI ETF (HLTH) had an operating margin of -556.6% in fiscal year 2023, reflecting the profitability of core business operations before interest and taxes.

What is Tema Healthcare AI ETF's net profit margin?

Tema Healthcare AI ETF (HLTH) had a net profit margin of -526.5% in fiscal year 2023, representing the share of revenue converted into profit after all expenses.

What is Tema Healthcare AI ETF's return on equity (ROE)?

Tema Healthcare AI ETF (HLTH) has a return on equity of -149.2% for fiscal year 2023, measuring how efficiently the company generates profit from shareholder equity.

What is Tema Healthcare AI ETF's free cash flow?

Tema Healthcare AI ETF (HLTH) generated -$147.0M in free cash flow during fiscal year 2023. This represents a 9.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Tema Healthcare AI ETF's operating cash flow?

Tema Healthcare AI ETF (HLTH) generated -$137.8M in operating cash flow during fiscal year 2023, representing cash generated from core business activities.

What are Tema Healthcare AI ETF's total assets?

Tema Healthcare AI ETF (HLTH) had $339.8M in total assets as of fiscal year 2023, including both current and long-term assets.

What are Tema Healthcare AI ETF's capital expenditures?

Tema Healthcare AI ETF (HLTH) invested $9.2M in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

How much does Tema Healthcare AI ETF spend on research and development?

Tema Healthcare AI ETF (HLTH) invested $150.6M in research and development during fiscal year 2023.

How many shares does Tema Healthcare AI ETF have outstanding?

Tema Healthcare AI ETF (HLTH) had 155M shares outstanding as of fiscal year 2023.

What is Tema Healthcare AI ETF's current ratio?

Tema Healthcare AI ETF (HLTH) had a current ratio of 2.54 as of fiscal year 2023, which is generally considered healthy.

What is Tema Healthcare AI ETF's debt-to-equity ratio?

Tema Healthcare AI ETF (HLTH) had a debt-to-equity ratio of 0.36 as of fiscal year 2023, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Tema Healthcare AI ETF's return on assets (ROA)?

Tema Healthcare AI ETF (HLTH) had a return on assets of -109.9% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

What is Tema Healthcare AI ETF's cash runway?

Based on fiscal year 2023 data, Tema Healthcare AI ETF (HLTH) had $80.9M in cash against an annual operating cash burn of $137.8M. This gives an estimated cash runway of approximately 7 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Tema Healthcare AI ETF's Altman Z-Score?

Tema Healthcare AI ETF (HLTH) has an Altman Z-Score of -5.78, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Tema Healthcare AI ETF's Piotroski F-Score?

Tema Healthcare AI ETF (HLTH) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Tema Healthcare AI ETF's earnings high quality?

Tema Healthcare AI ETF (HLTH) has an earnings quality ratio of 0.37x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Tema Healthcare AI ETF cover its interest payments?

Tema Healthcare AI ETF (HLTH) has an interest coverage ratio of -340.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.